Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous navigation-assisted versus open posterior fixation for thoracolumbar fractures in ankylosing spinal diseases: a single-institution 15-year cohort analysis.

Journal of neurosurgery. Spine·2026
Same author

Identification of the promoter region of the human P2RX7 gene.

Purinergic signalling·2026
Same author

Radiographic predictors of lumbar disc re-herniation requiring repeat discectomy or fusion: a matched retrospective cohort analysis.

The spine journal : official journal of the North American Spine Society·2026
Same author

Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance.

Neurochemistry international·2025
Same author

Full Endoscopic Peripheral Nerve Sheath Tumor Resection With Triportal Bimanual Maneuver: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)·2025
Same author

Thoracic stenosis decompression using Bi-portal endoscopic technique.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2025
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Drug Development.

Xin Huang1,2,3, Jennica Wang1, Yoshiteru Kagawa1,2

  • 1The University of Melbourne, Parkville, VIC, Australia.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

Apolipoprotein E (ApoE) isoforms, ApoE3 and ApoE4, inhibit phagocytosis in immune cells. While both reduce amyloid-beta (Aβ) uptake, ApoE4 shows less Aβ binding, potentially initiating Alzheimer's disease (AD) pathogenesis.

More Related Videos

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Related Experiment Videos

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • The APOE ε4 allele is a major genetic risk factor for Alzheimer's disease (AD), linked to earlier onset.
  • ApoE4 is implicated in amyloid-beta (Aβ) aggregation and lipid droplet formation in early AD pathogenesis.
  • The role of ApoE in Aβ phagocytosis and its differential effects based on isoform remain unclear.

Purpose of the Study:

  • To investigate the impact of Apolipoprotein E3 (ApoE3) and Apolipoprotein E4 (ApoE4) on Aβ phagocytosis by immune cells.
  • To determine if ApoE isoforms differentially affect Aβ clearance mechanisms.
  • To explore the relationship between ApoE, lipid droplet formation, and phagocytic activity.

Main Methods:

  • Utilized HEK293 cells expressing ApoE3 or ApoE4 to isolate proteins.
  • Employed real-time flow cytometry with THP-1 monocytes and fluorescent beads to assess phagocytosis.
  • Used BV2 microglia with pHrodo-red Aβ oligomers and LipidSpot staining to evaluate Aβ endocytosis and lipid droplet formation.

Main Results:

  • Both ApoE3 and ApoE4 dose-dependently inhibited phagocytosis of beads by monocytes.
  • ApoE isoforms reduced Aβ oligomer endocytosis and acidification in microglia.
  • ApoE4 demonstrated decreased binding of Aβ oligomers compared to ApoE3, while both isoforms reduced lipid droplet formation.

Conclusions:

  • ApoE isoforms inhibit phagocytic activity in monocytes and microglia, irrespective of the specific isoform.
  • Reduced Aβ surface binding by ApoE4 suggests impaired Aβ chaperoning, potentially contributing to initial Aβ aggregation in AD.
  • These findings reveal isoform-specific mechanisms of ApoE in Alzheimer's disease pathogenesis.